EPA Content Research Articles

Pengaruh pemberian minyak ikan terhadap konsentrasi asam lemak dan gejala klinis malaria

The aim of the study is to find out the effects of fish oil supplementation on fatty acids concentration (Eicosapentanoat Acid and Docosahexaenoat Acid), fever attacks and Dikke Drupple (DDR) interpretation of samples. This study was designed as “A Randomized Double Blind Pretest and Post-test Controled Group“. Samples were divided into two groups, experiment group with fish oil suplementation (8% EPA, 35 DHA) and control group (placebo) for 8 weeks. This study was conducted in a malaria endemic, Kadaila village, subdistrict of Karossa, District of Mamuju in 2003. The result of the study showed significant increased concentration of EPA and DHA of the experiment group than the control group (p < 0,05). The fever attack was significantly decreased (p < 0,05) in experiment group than the control group, while DDR was not significantly different (p > 0,05) between two groups.

DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells.

Dietary supplementation with ω-3 polyunsaturated fatty acids (PUFAs) has been reported to enhance the sensitivity of tumor cells towards chemotherapy. Most enhancing effects are described for ω-3 PUFAs EPA and DHA; less evidence is available with the intermediate DPA. We studied the chemotherapy enhancing effects of EPA, DPA and DHA in murine colon C26 adenocarcinoma cells and showed that DPA displayed similar chemosensitizing effects as EPA. Moreover, EPA supplementation increased cellular DPA content. In a C26 tumor-bearing mouse model, we studied the incorporation of ω-3 PUFA in tumor and skeletal muscle after a diet with different ω-3 PUFA sources. Although little DPA was present in the fatty acid food sources, in those that contained considerable EPA concentrations, DPA levels were higher in tumor and muscle tissue. From these studies, we conclude that EPA and DPA show chemosensitizing effects and that intake of EPA or EPA-containing nutrition leads to increased cellular DPA content by elongation. These findings support the use of ω-3 PUFA containing nutritional supplementations in cancer patients during chemotherapy treatment.

Development and evaluation of a sensitive, Diffusive Gradients in Thin-Films (DGT) method for determining microcystin-LR concentrations in freshwater and seawater

A Diffusive Gradients in Thin-Films (DGT) passive sampling technique was developed for microcystin-LR (MC-LR), one of the most common and toxic microcystins. Three types of resins (HP20, SP700, and XAD18) were evaluated for MC-LR uptake kinetics, capacities, and extraction efficiencies and simple procedures were developed for determining MC-LR concentration in binding disc extracts by Adda-ELISA (U.S. EPA Method 546). The XAD18-DGT/Adda-ELISA method had a 7-d deployment time detection limit of ≈0.05 μg/L and capacity of >250 μg/L of MC-LR in water samples which encompass U.S. EPA and WHO advisory concentrations for drinking and recreational waters. The XAD18-DGT/Adda-ELISA method determined time-averaged MC-LR concentrations in waters with wide ranging pH (4.9–8.3) and ionic strength (0.04–0.8 M) under well-stirred and quiescent conditions with 90–101% accuracy. In addition to high sensitivity and accuracy, the method is simple, inexpensive, and applicable for determining MC-LR and related MCs concentrations in waterbodies with wide ranging chemical characteristics and hydrodynamic conditions.

Chlorella vulgaris cultivation in airlift photobioreactor with transparent draft tube: effect of hydrodynamics, light and carbon dioxide on biochemical profile particularly ω-6/ω-3 fatty acid ratio

Chlorella vulgaris is used for food and feed applications due to its nutraceutical, antioxidant and anticancer properties. An airlift photobioreactor comprising transparent draft tube was used for C. vulgaris cultivation. The effect of reactor parameters like hydrodynamics (0.3-1.5vvm), light intensity (85-400μmolm-2s-1), photoperiod (12-24h) and gas-phase carbon dioxide (CO2) concentration (5-15% v/v) were evaluated on microalgae and associated bacterial growth, biochemical profile; with special emphasis on ω-3, ω-6 fatty acids, and vitamin B12. The optimal growth of C. vulgaris without CO2 supplementation was observed at 1.2vvm, which was associated with higher algal productivity, chlorophyll, vitamin B12 content, and bacterial load along with 72% of nitrate removal. The higher light intensity (400μmolm-2s-1) and photoperiod (24:0) increased biomass productivity and ω-3 fatty acid content (in lipid) up to 2-3 fold. The elevated levels of gas-phase CO2 concentration (15% v/v) enhanced EPA content up to 7% and biomass productivity up to 171mgL-1day-1. However, the increase in CO2 concentration lowered vitamin B12 content (up to 30%) and bacterial load (2-3 log). Also, all the cultivation conditions favoured desirable ω-6/ω-3 ratio(in the range of 1-2).

Effects of Shrimp Waste Types and Their Cooking on Properties of Extracted Astaxanthin and Its Characteristics in Liposomes

This study was aimed to evaluate the effects of shrimp waste types (fresh head, cooked head, fresh shell and cooked shell) and of cooking these wastes on the properties of astaxanthin. The astaxanthin was subject to liposomal encapsulation and its characteristics were determined. Astaxanthin was extracted from fresh and cooked (90°C for 15 min) materials, and then yield, astaxanthin content, antioxidant activities (DPPH and ABTS scavenging assays) and fatty acid profiles were determined. Phospholipid was used at various concentrations (2, 3 and 4 % w/v) to prepare astaxanthin-loaded liposomes, which were further evaluated for particle size, zeta potential, antioxidant activity (DPPH scavenging assays) and outer structure by confocal laser scanning microscope. The results showed that fresh shrimp heads gave the highest percent yield (30.49 mg extract/g raw material), but the highest astaxanthin content was found in fresh shrimp shells (14.65 mg/g). Shrimp heads and shrimp shells, both fresh and cooked, were significantly different (p<0.05) in terms of their antioxidant activity (based on DPPH and ABTS scavenging assays). Three fatty acids, palmitic acid, oleic acid and linoleic acid were most abundant and found in all samples. However, extract from fresh shrimp shells showed the highest EPA and DHA content of 10.48 % and 11.62 %, respectively. Astaxanthin-loaded liposomes derived were different in size in that the higher concentration, the larger liposomes produced. Liposomes prepared from 4% (w/v) phospholipid at 50 amplitude gave the highest %DPPH scavenging activity of 79.23.

Maternal polymorphisms in the FADS1 and FADS2 genes modify the association between PUFA ingestion and plasma concentrations of omega-3 polyunsaturated fatty acids

There is a lack of studies about polymorphisms in FADS genes in pregnant women. We aimed to verify the interaction between three FADS gene polymorphisms (rs174561; rs174575; rs3834458) and dietary α-linolenic acid (ALA) or linoleic/α-linolenic acid ratio (LA/ALA) and plasma concentrations of omega-3 (n−3) PUFAs in pregnant women. Of the 250 women evaluated, the homozygous for the rs174561 and rs3834458 minor allele had high plasma ALA concentrations at the highest ALA and LA/ALA ratio tertile (p < 0.05). Plasma concentrations of EPA and DHA were not influenced by diet. For the rs174575 SNP, pregnant women who carried the minor allele presented lower proportions of plasma EPA in the second LA/ALA ratio tertile (p < 0.05). Increased dietary intake of ALA and LA/ALA ratio promoted plasma ALA accumulation in homozygotes for the minor allele rs174561 and rs3834458. Moderate intake of LA/ALA ratio may reduce plasma concentration of EPA in pregnants carrying the rs174575 minor allele.

Browning reduces the availability—but not the transfer—of essential fatty acids in temperate lakes

Abstract Atmospheric changes are leading to the browning of northern lakes (i.e. increases in catchment‐derived dissolved organic matter [DOM]), consequently altering phytoplankton biomass and community composition. We hypothesised that lake browning and the concurrent increase in nutrients drive a shift towards greater cyanobacteria biomass. We further hypothesised that, as a consequence of this shift in phytoplankton, the content of ω‐3 (n‐3) essential fatty acids (EFA) in seston would decline, affecting the subsequent transfer of EFA to consumers across the plant–animal interface in pelagic regions of lakes. We tested these hypotheses in the epilimnion of 30 temperate lakes in Ontario (Canada), representing a gradient of lake browning, with dissolved organic carbon (DOC) ranging from 2 to 10 mg/L and total phosphorus ranging from 6.0 to 48.5 μg/L. In each of these lakes, the concentration and composition of DOM, the biomass of phytoplankton and cyanobacteria, and the EFA content of seston, cladocerans, and copepods were measured. An increase in aromatic DOM was associated with increased phytoplankton and cyanobacteria biomass. Due to the lower content of the EFA eicosapentaenoic acid (EPA; 20:5n‐3) and docosahexaenoic acid (DHA; 22:6n‐3) in cyanobacteria, this increase in phytoplankton biomass was associated with a decline in EPA and DHA content in lake seston. However, there was no significant change in EFA content of cladocerans and copepods. This homeostatic (diet‐independent) EFA composition in zooplankton suggested that, as the phytoplankton community shifted towards more cyanobacteria with lower EFA content, the cladocerans and copepods may have met their nutritional requirements by relying on alternative food sources (e.g. heterotrophic ciliates and flagellates) capable of either trophically upgrading phytoplankton‐produced EPA and DHA, or synthesising EPA and DHA de novo. Results from this study indicate that increasing DOC from low (2 mg DOC/L) to moderate levels (15 mg DOC/L) may increase the importance of the microbial pathway in the trophic transfer of EPA and DHA from basal resources to zooplankton. However, this supplementary transfer of EFA through the microbial food web may not sustain high EPA and DHA levels in zooplankton when lake browning starts to limit primary production (&gt;15 mg DOC/L).

Reduction in the exposure risk of farmer from e-waste recycling site following environmental policy adjustment: A regional scale view of PAHs in paddy fields

Farmland contamination by polycyclic aromatic hydrocarbons (PAHs) has drawn increasing attention across China with enhanced regulations and environmental policies proposed by government to protect soil environment safety. As the informal electronic waste (e-waste) dismantling activities were forbidden under recent environmental regulation, this study compared levels, compositions, spatial distributions, human health risks of PAHs in paddy soil within the vicinity of an e-waste recycling area in southeastern China, with 129 and 150 soil samples collected in 2011 and 2016, respectively. The soil contamination was dominated with high molecular weight PAHs. The mean concentration of EPA 16 PAHs decreased from 590.4 ± 337.2 μg kg−1 in 2011 to 407.3 ± 232.2 μg kg−1 in 2016. Distribution maps of soil PAHs concentration displayed the temporal change in spatial. Principal component analysis together with diagnostic ratios revealed the combustion of biomass and coal in industrial and unregulated e-waste dismantling were the main sources of PAHs in the study area. Both deterministic and probabilistic assessments demonstrated reduced exposure risk for farmers from 2011 to 2016. Sensitivity analysis revealed that exposure frequency (EF) is the most influential parameter for the total variance in the risk assessment model. This study implied that the more stringent environmental policy and regulation can lead reductions in soil contamination with PAHs.

Replacement of dietary fishmeal by Antarctic krill meal on growth performance, intestinal morphology, body composition and organoleptic quality of large yellow croaker Larimichthys crocea

The present study investigated the growth performance, intestinal morphology, body composition and organoleptic quality of large yellow croaker Larimichthys crocea fed a diet containing different proportions of Antarctic krill Euphausia superba meal (0, 15, 30, 45, 60 and 75%) as a substitute for fishmeal. After a 9-week feeding trial, results showed that the specific growth rate and feed efficiency ratio were not negatively affected by dietary krill meal levels. Increasing levels of dietary krill meal linearly and quadratically increased significantly FI (P < .05). Significant positive linear trends were found between the increasing levels of dietary krill meal and carotenoid concentrations, redness (a*), yellowness (b*) in skin (P < .05). And the color can be distinguished by the human eye when 15% fishmeal protein was replaced by krill meal protein due to the total color difference (ΔE) was >3. Texture and pH in muscle were not negatively affected, however, liquid holding capacity linearly decreased (P < .05). The increasing dietary krill meal resulted in a linear decrease in most of free amino acids and a linear increase in inosinic acid (P < .05). The concentrations of EPA was linearly increased with the increasing krill meal level, n-3/n-6 ratio ranged from 0.68–0.91 within the human dietary requirements. Total amino acid profile kept unchanged among all the treatments. Although the increase of dietary krill meal significantly linearly increased the content of fluorine in muscle (P < .05), the highest content was within the safe edible limit for human. The expression levels of mTOR, 4E-BP1, eIF4E, S6K1, S6 genes related to TOR signaling pathway and phosphorylation of mTOR were not significantly changed among all treatment. These results suggested that Antarctic krill meal could be a viable alternative dietary protein source for large yellow croaker. And 6.59%–32.93% of dietary krill meal can result in a better skin color and fatty acid nutritional value in muscle without negative effects on growth performance of large yellow croaker.

Compound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation: a randomized control trial

It has long been believed that DHA supplementation increases plasma EPA via the retroconversion pathway in mammals. However, in rodents this increase in EPA is likely due to a slower metabolism of EPA, but this has never been tested directly in humans. The aim of this study was to use the natural variations in 13C:12C ratio (carbon-13 isotopic abundance[δ13C]) of n-3 PUFA supplements to assess n-3 PUFA metabolism following DHA or EPA supplementation in humans. Participants (aged 21.6±2.2 y) were randomly assigned into 1 of 3 supplement groups for 12 wk: 1) olive oil control, 2) ∼3 g/d DHA, or 3) ∼3 g/d EPA. Blood was collected before and after the supplementation period, and concentrations and δ13C of plasma n-3 PUFA were determined. DHA supplementation increased (P<0.05) plasma EPA concentrations by 130% but did not affect plasma δ13C-EPA (-31.0±0.30 to -30.8±0.19, milliUrey±SEM, P>0.05). In addition, EPA supplementation did not change plasma DHA concentrations (P>0.05) but did increase plasma δ13C-DHA (-27.9±0.2 to -25.6±0.1, P<0.05) toward δ13C-EPA of the supplement (-23.5±0.22). EPA supplementation increased plasma concentrations of EPA and docosapentaenoic acid (DPAn-3) by 880% and 200%, respectively, and increased plasma δ13C-EPA (-31.5±0.2 to -25.7±0.2) and δ13C-DPAn-3 (-28.9±0.3 to -25.0±0.1) toward δ13C-EPA of the supplement. In this study, we show that the increase in plasma EPA following DHA supplementation in humans does not occur via retroconversion, but instead from a slowed metabolism and/or accumulation of plasma EPA. Furthermore, substantial amounts of supplemental EPA can be converted into DHA. δ13C of n-3 PUFA in humans is a powerful and underutilized tool that can track dietary n-3 PUFA and elucidate complex metabolic questions. This trial was registered at clinicaltrials.gov as NCT03378232.

DHA intake interacts with ELOVL2 and ELOVL5 genetic variants to influence polyunsaturated fatty acids in human milk

Endogenous synthesis of PUFAs is mediated by genes controlling fatty acid elongases 2 and 5 (ELOVL2 and ELOVL5) and by exogenous DHA intake. Associations between elongases and PUFA levels probably involve genetic variants of ELOVL and changes in DHA intake, but data about their combined effect on PUFA levels are sparse. We hypothesized that each factor would directly affect PUFAs and that interactions between haplotypes and DHA intake would influence PUFAs. We explored four levels of DHA intake in pregnant Chinese Han women and 10 SNPs in the ELOVL genes to determine associations with PUFAs in breast milk. The SNP rs3798713 and 3-SNP haplotype (rs2281591, rs12332786, and rs3798713) in ELOVL2 were associated with linoleic acid (LA) concentrations. However, carriers of the 3-SNP haplotype with higher DHA intake (second quartile: 14.58-43.15 mg/day) had higher concentrations of LA, arachidonic acid, EPA, and DHA compared with the interaction baseline. In ELOVL5, five SNPs (rs2294867, rs9357760, rs2397142, rs209512, and rs12207094) correlated with PUFA changes. Compared with those who had the 5-SNP haplotype C-A-C-G-A and low DHA intake (<14.58 mg/day), carriers with other haplotypes (A-A-C-A-A or C-A-C-A-A) and high DHA intake (≥118.82 mg/day) had increased EPA levels after adjustments for age and BMI. This study showed that maternal genetic variants in ELOVL2 and ELOVL5 were associated with PUFA levels in breast milk and that the combination of SNP haplotypes and higher DHA intake increased PUFA concentrations.

Concentration of EPA and DHA from Refined Salmon Oil by Optimizing the Urea⁻Fatty Acid Adduction Reaction Conditions Using Response Surface Methodology.

This research focused on obtaining eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3) (EPA+DHA) concentrates from refined commercial salmon oil (RCSO). Independent variables of the complexation process were optimized by means of the application of response surface methodology (RSM) in order to obtain the maximum content of such fatty acids (FAs). As a result of employing the optimized conditions for all the variables (6.0, urea:FA content ratio; −18.0 °C, crystallization temperature; 14.80 h, crystallization time; 500 rpm, stirring speed), high contents of EPA and DHA could be obtained from RCSO, achieving increases of 4.1 and 7.9 times in the concentrate, with values of 31.20 and 49.31 g/100 g total FA, respectively. Furthermore, a 5.8-time increase was observed for the EPA + DHA content, which increased from 13.78 to 80.51 g/100 g total FA. It is concluded that RCSO can be transformed into a profitable source of EPA and DHA (EPA+DHA), thus leading to a product with higher commercial value.

Pharmacokinetics of omega-3 fatty acids in patients with severe sepsis compared with healthy volunteers: A prospective cohort study

Pharmacokinetics (PK) of pharmaceuticals and pharmaconutrients are poorly understood in critically ill patients, and dosing is often based on healthy subject data. This might be particularly problematic with enteral medications due to metabolic abnormalities and impaired gastrointestinal tract absorption common in critically ill patients. Utilizing enteral fish oil, this study was undertaken to better understand and define PK of enteral omega-3 fatty acids (eicospentaenoic acid [EPA] and docosahexaenoic acid [DHA]) in critically ill patients with severe sepsis. Healthy volunteers (n=15) and mechanically ventilated (MV) adults with severe sepsis (n=10) were recruited and received 9.75g EPA and 6.75g DHA daily in two divided enteral doses of fish oil for 7 days. Volunteers continued their normal diet without other sources of fish oil, and sepsis patients received standard enteral feeding. Blood was collected at frequent intervals during the 14-day study period. Peripheral blood mononuclear cells (PMBCs) and neutrophils were isolated and analyzed for membrane fatty acid (FA) content. Mixed linear models and t-tests were used to analyze changes in FA levels over time and FA levels at individual time points, respectively. PK parameters were obtained based on single compartment models of EPA and DHA kinetics. Healthy volunteers were 41.1±10.3 years; 67% were women. In patients with severe sepsis (55.6±13.4 years, 50% women), acute physiologic and chronic health evaluation (APACHE) II score was 27.2±8.8at ICU admission and median MV duration was 10.5 days. Serum EPA and DHA were significantly lower in sepsis vs. healthy subjects over time. PBMC EPA concentrations were generally not different between groups over time, while PBMC DHA was higher in sepsis patients. Neutrophil EPA and DHA concentrations were similar between groups. The half-life of EPA in serum and neutrophils was significantly shorter in sepsis patients, whereas other half-life parameters did not vary significantly between healthy volunteers and sepsis patients. While incorporation of n-3 FAs into PBMC and neutrophil membranes was relatively similar between healthy volunteers and sepsis patients receiving identical high doses of fish oil for one week, serum EPA and DHA were significantly lower in sepsis patients. These findings imply that serum concentrations and EPA and DHA may not be the dominant driver of leukocyte membrane incorporation of EPA and DHA. Furthermore, lower serum EPA and DHA concentrations suggest that either these n-3 FAs were being metabolized rapidly in sepsis patients or that absorption of enteral medications and pharmaconutrients, including fish oil, may be impaired in sepsis patients. If enteral absorption is impaired, doses of enteral medications administered to critically ill patients may be suboptimal.

Direct enzymatic ethanolysis of potential Nannochloropsis biomass for co-production of sustainable biodiesel and nutraceutical eicosapentaenoic acid

BackgroundMarine microalga Nannochloropsis is a promising source for the production of renewable and sustainable biodiesel in replacement of depleting petroleum. Other than biodiesel, Nannochloropsis is a green and potential resource for the commercial production of nutraceutical eicosapentaenoic acid (EPA, C20:5). In recent studies, low-value biodiesel can be achieved by transesterification of Nannochloropsis biomass. However, it is undoubtedly wasteful to produce microalgal biodiesel containing EPA from nutritional and economical aspects. A new strategy was addressed and exploited to produce low-value bulky biodiesel along with EPA enrichment via enzymatic ethanolysis of Nannochloropsis biomass with a specific lipase.ResultsCellulase pretreatment on Nannochloropsis sp. biomass significantly improved the biodiesel conversion by direct ethanolysis with five enzymes from Candida antarctica (CALA and CALB), Thermomyces lanuginosus (TL), Rhizomucor miehei (RM), and Aspergillus oryzae (PLA). Among these five biocatalysts, CALA was the best suitable enzyme to yield high biodiesel conversion and effectively enrich EPA. After optimization, the maximum biodiesel conversion (46.53–48.57%) was attained by CALA at 8:1 ethanol/biomass ratio (v/w) in 10–15% water content with 10% lipase weight at 35 °C for 72 h. Meanwhile, EPA (60.81%) was highly enriched in microalgae NPLs (neutral lipids and polar lipids), increasing original EPA levels by 1.51-fold. Moreover, this process was re-evaluated with two Nannochloropsis species (IMET1 and Salina 537). Under the optimized conditions, the biodiesel conversions of IMET1 and Salina 537 by CALA were 63.41% and 54.33%, respectively. EPA contents of microalgal NPLs were 50.06% for IMET1 and 53.73% for Salina 537.ConclusionCALA was the potential biocatalyst to discriminate against EPA in the ethanolysis of Nannochloropsis biomass. The biodiesel conversion and EPA enrich efficiency of CALA were greatly dependent on lipidic class and fatty acid compositions of Nannochloropsis biomass. CALA-catalyzed ethanolysis with Nannochloropsis biomass was a promising approach for co-production of low-value biodiesel and high-value microalgae products rich in EPA.

Linkage of Marine Bacterial Polyunsaturated Fatty Acid and Long-Chain Hydrocarbon Biosynthesis.

Various marine gamma-proteobacteria produce omega-3 polyunsaturated fatty acids, such as eicosapentaenoic acid (20:5, EPA) and docosahexaenoic acid (22:6, DHA), which are incorporated into membrane phospholipids. Five genes, designated pfaABCDE, encode the polyketide/fatty acid synthase necessary for production of these long-chain fatty acids. In addition to de novo biosynthesis of EPA and DHA, the “Pfa synthase” is also involved with production of a long-chain polyunsaturated hydrocarbon product (31:9, PUHC) in conjunction with the oleABCD hydrocarbon biosynthesis pathway. In this work, we demonstrate that OleA mediates the linkage between these two pathways in vivo. Co-expression of pfaA-E along with oleA from Shewanella pealeana in Escherichia coli yielded the expected product, a 31:8 ketone along with a dramatic ∼10-fold reduction in EPA content. The decrease in EPA content was independent of 31:8 ketone production as co-expression of an OleA active site mutant also led to identical decreases in EPA content. We also demonstrate that a gene linked with either pfa and/or ole operons in diverse bacterial lineages, herein designated pfaT, plays a role in maintaining optimal production of Pfa synthase derived products in Photobacterium and Shewanella species.

Preliminary estimation of the export of omega-3 polyunsaturated fatty acids from aquatic to terrestrial ecosystems in biomes via emergent insects

Some terrestrial consumers may be limited by food quality, namely by contents of essential polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (20:5n−3, EPA) and docosahexaenoic acid (22:6n−3, DHA) in their food. Since EPA and DHA are mainly produced in aquatic ecosystems, for future estimating of the potential limitation by food quality in global scale, the water-land fluxes of these PUFA with the biomass of emergent aquatic insects in several biomes were calculated. The water /land area ratios for each biome were calculated by dividing the water area of each biome by its terrestrial area. Data on insect emergence from water bodies (g of dry mass m−2 year−1), were summarized and averaged for each biome. From available data, EPA and DHA contents (mg g−1dry mass), in the biomass of emergent aquatic insects were calculated first so that annual fluxes of PUFA to land area via aquatic insect emergence could be estimated for each biome. PUFA fluxes occurred between the biomes, ranging from 0.04 to 4.39 mg m−2 year−1. In this study, the aquatic PUFA supply to land area appeared to be significantly lower than estimated earlier. This suggests that terrestrial consumers may experience food quality limitations mediated by shortage of PUFA compounds.

The sociodemographic characteristics and dietary and blood plasma fatty acid profiles of elderly Saudi women with Alzheimer disease

BackgroundAlzheimer’s disease (AD) is a progressive neurodegenerative disease, and due to various physiological and psychological factors the patients are at risk of nutritional insufficiencies. The purpose of this study was to assess the dietary fatty acid intake and its effect on plasma fatty acids in elderly Saudi women and to compare the differences in their food and plasma fatty acid profile on the basis of their residence.MethodsA total of 76 elderly women (50–100 years) were recruited through a random sampling method. A structured proforma was designed to gather information related to their age, income, dietary habits, and presence of any disease and awareness of AD. A 24-h dietary recall method for 3 days and food frequency questionnaire, concentrating on fish consumption and consumption of foods rich in ω-3 fatty acids, which was planned by dietitians, was used for dietary assessment. The gathered data were then analyzed using food processor software. The blood samples were collected to determine plasma fatty acids.ResultsThe mean age of women diagnosed with AD was more than 75 years, and the prevalence of illiteracy was higher among AD subjects. As compared to the AD group, the concentration of LA and total ω-6 was significantly (p ≤ 0.05) higher in the control group from both recruitment sites [National Guard Health Affairs, King Abdulaziz Medical City, Riyadh (NGH) and Social Welfare Homes for the Elderly (SWH)]. Similarly, the concentrations of EPA, DHA, and ω-3 were also slightly higher in the control group at both sites, but the difference between the control and AD subjects was only significant (p ≤ 0.05) in subjects from NGH. We found no significant difference in the ω-6/ ω-3 ratio between groups. Also, no significant difference was found in the mean level of the plasma fatty acid when comparing the control and AD groups. The concentration of DHA in controls only and AA, EPA and ω-6 in both control and AD were significant (although weakly) correlated with their respective dietary intakes. No correlations were found between the intake of 18 C precursors (LA and ALA) and plasma levels of their long chain derivatives (AA, EPA, and DHA). Education, income, overall health status and the concentration of various fatty acids from food was higher and better in subjects from SWH than NGH. The lower plasma level indicates lower impaired systemic availability of several nutrients.ConclusionWe found that dietary intervention might play a role in the prevention of AD.

Incorporation of Omega-3 Fatty Acids Into Human Skeletal Muscle Sarcolemmal and Mitochondrial Membranes Following 12 Weeks of Fish Oil Supplementation.

Fish oil (FO) supplementation in humans results in the incorporation of omega-3 fatty acids (FAs) eicosapentaenoic acid (EPA; C20:5) and docosahexaenoic acid (DHA; C20:6) into skeletal muscle membranes. However, despite the importance of membrane composition in structure–function relationships, a paucity of information exists regarding how different muscle membranes/organelles respond to FO supplementation. Therefore, the purpose of the present study was to determine the effects 12 weeks of FO supplementation (3g EPA/2g DHA daily) on the phospholipid composition of sarcolemmal and mitochondrial fractions, as well as whole muscle responses, in healthy young males. FO supplementation increased the total phospholipid content in whole muscle (57%; p < 0.05) and the sarcolemma (38%; p = 0.05), but did not alter the content in mitochondria. The content of omega-3 FAs, EPA and DHA, were increased (+3-fold) in whole muscle, and mitochondrial membranes, and as a result the omega-6/omega-3 ratios were dramatically decreased (-3-fold), while conversely the unsaturation indexes were increased. Intriguingly, before supplementation the unsaturation index (UI) of sarcolemmal membranes was ∼3 times lower (p < 0.001) than either whole muscle or mitochondrial membranes. While supplementation also increased DHA within sarcolemmal membranes, EPA was not altered, and as a result the omega-6/omega-3 ratio and UI of these membranes were not altered. All together, these data revealed that mitochondrial and sarcolemmal membranes display unique phospholipid compositions and responses to FO supplementation.

Enhancing Omega-3 Long-Chain Polyunsaturated Fatty Acid Content of Dairy-Derived Foods for Human Consumption.

Omega-3 polyunsaturated fatty acids (n-3 PUFA) are termed essential fatty acids because they cannot be synthesized de novo by humans due to the lack of delta-12 and delta-15 desaturase enzymes and must therefore be acquired from the diet. n-3 PUFA include α-linolenic acid (ALA, 18:3n-3), eicosapentaenoic (EPA, 20:5n-3), docosahexaenoic (DHA, 22:6n-3), and the less recognized docosapentaenoic acid (DPA, 22:5n-3). The three long-chain (≥C20) n-3 PUFA (n-3 LC-PUFA), EPA, DHA, and DPA play an important role in human health by reducing the risk of chronic diseases. Up to the present time, seafood, and in particular, fish oil-derived products, have been the richest sources of n-3 LC-PUFA. The human diet generally contains insufficient amounts of these essential FA due largely to the low consumption of seafood. This issue provides opportunities to enrich the content of n-3 PUFA in other common food groups. Milk and milk products have traditionally been a major component of human diets, but are also among some of the poorest sources of n-3 PUFA. Consideration of the high consumption of milk and its processed products worldwide and the human health benefits has led to a large number of studies targeting the enhancement of n-3 PUFA content in dairy products. The main objective of this review was to evaluate the major strategies that have been employed to enhance n-3 PUFA content in dairy products and to unravel potential knowledge gaps for further research on this topic. Nutritional manipulation to date has been the main approach for altering milk fatty acids (FA) in ruminants. However, the main challenge is ruminal biohydrogenation in which dietary PUFA are hydrogenated into monounsaturated FA and/or ultimately, saturated FA, due to rumen microbial activities. The inclusion of oil seed and vegetable oil in dairy animal diets significantly elevates ALA content, while the addition of rumen-protected marine-derived supplements is the most effective way to increase the concentration of EPA, DHA, and DPA in dairy products. In our view, the mechanisms of n-3 LC-PUFA biosynthesis pathway from ALA and the biohydrogenation of individual n-3 LC-PUFA in ruminants need to be better elucidated. Identified knowledge gaps regarding the activities of candidate genes regulating the concentrations of n-3 PUFA and the responses of ruminants to specific lipid supplementation regimes are also critical to a greater understanding of nutrition-genetics interactions driving lipid metabolism.

Long-chain ω-3 polyunsaturated fatty acids in the prevention of diseases in adults and children: a view of the clinical pharmacologist

Adequate and balanced intake of ω-3 long-chain polyunsaturated fatty acids (ω-3 LCPUFA) is important throughout life, and directly affects health status: from preconception and pregnancy to the prevention of various diseases. Russia geographically belongs to regions with a low level of consumption of eicosapentaenoic and docosahexaenoic acids. In addition, gender characteristics and genetic polymorphisms underlie the variability of the synthesis of ω-3 LCPUFA in the human organism from alpha-linolenic acid. ω-3 LCPUFA play one of the key roles in the human organism: they regulate lipid metabolism, have a positive effect on cognitive functions, have anti-inflammatory activity, and contribute to the prolongation of pregnancy. ω-3 LCPUFA should be ingested in sufficient quantities, since they are essential nutrients, be in the form of release, provide high compliance for admission and be balanced in content of EPA and DHA.